Rockefeller Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$403 Hold
140
﹤0.01% 4619
2026
Q1
$274 Buy
140
+123
+724% +$289 ﹤0.01% 4590
2025
Q4
$46 Hold
17
﹤0.01% 4646
2025
Q3
$72 Buy
+17
New +$75 ﹤0.01% 4383
2023
Q2
Sell
-13,275
Closed -$82K 1889
2023
Q1
$82K Buy
13,275
+4,825
+57% +$26.9K ﹤0.01% 1903
2022
Q4
$39K Sell
8,450
-152
-2% -$749 ﹤0.01% 2500
2022
Q3
$40K Sell
8,602
-321
-4% -$2.02K ﹤0.01% 2465
2022
Q2
$52K Sell
8,923
-6
-0.1% -$67 ﹤0.01% 2261
2022
Q1
$172K Buy
8,929
+366
+4% +$8.39K ﹤0.01% 1751
2021
Q4
$279K Buy
8,563
+421
+5% +$16.9K ﹤0.01% 1524
2021
Q3
$333K Buy
8,142
+3,547
+77% +$129K ﹤0.01% 1406
2021
Q2
$164K Sell
4,595
-2,297
-33% -$84.8K ﹤0.01% 1586
2021
Q1
$268K Buy
6,892
+6,834
+11,783% +$307K ﹤0.01% 1240
2020
Q4
$2K Buy
58
+51
+729% +$2.34K ﹤0.01% 2635
2020
Q3
$0 Buy
+7
New +$371 ﹤0.01% 2649

Other funds holding GDRX

Rockefeller Capital Management's GDRX Position: Q2 2026 in Review

Rockefeller Capital Management held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 140 shares worth $403. The position accounts for ﹤0.01% of the portfolio, ranked #4619.

Rockefeller Capital Management first reported a position in GDRX in Q3 2020 and has held it in 15 quarters since. The position peaked at $333K in Q3 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Rockefeller Capital Management held 140 shares of GoodRx Holdings worth $403 as of Q2 2026.
  • Rockefeller Capital Management left its GoodRx Holdings share count unchanged in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4619 holding.
  • Rockefeller Capital Management first reported a position in GoodRx Holdings in Q3 2020 and has held it in 15 quarters since.
  • Rockefeller Capital Management's GoodRx Holdings position peaked at $333K in Q3 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.